Burden of migraine - Societal costs and therapeutic opportunities

被引:131
作者
Lipton, RB
Stewart, WF
vonKorff, M
机构
[1] ALBERT EINSTEIN COLL MED, DEPT NEUROL, BRONX, NY 10467 USA
[2] ALBERT EINSTEIN COLL MED, DEPT PSYCHIAT, BRONX, NY 10467 USA
[3] ALBERT EINSTEIN COLL MED, DEPT EPIDEMIOL, BRONX, NY 10467 USA
[4] ALBERT EINSTEIN COLL MED, DEPT SOCIAL MED, BRONX, NY 10467 USA
[5] INNOVAT MED RES, STAMFORD, CT USA
[6] JOHNS HOPKINS UNIV, SCH PUBL HLTH, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA
[7] GRP HLTH COOPERAT PUGET SOUND, CTR HLTH STUDIES, TACOMA, WA USA
关键词
D O I
10.1212/WNL.48.3_Suppl_3.4S
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine imposes an enormous health burden on individual headache sufferers and on society. The condition affects about 18% of women and about 6% of men across their lifespan. Because prevalence peaks during the most productive years, between the ages of 25 and 55, migraine is an important cause of lost work time. Despite the widespread underdiagnosis and undertreatment of migraine, health care costs for the condition are considerable. Add to this the indirect costs, in the form of absenteeism and reduced productivity at work, and the overall burden of migraine becomes apparent. Work loss is not uniformly distributed, with the most disabled half of migraineurs accounting for more than 80% of all work loss. Although improvements in health care delivery for migraine may increase direct cost (i.e., drug or medical care), this may be offset by savings in indirect costs (i.e., reduced and lost productivity).
引用
收藏
页码:S4 / S9
页数:6
相关论文
共 37 条
[1]  
[Anonymous], 1993, World Development Report 1993: Investing in Health
[2]   MIGRAINE, SUICIDAL IDEATION, AND SUICIDE ATTEMPTS [J].
BRESLAU, N .
NEUROLOGY, 1992, 42 (02) :392-395
[3]   MIGRAINE, PHYSICAL HEALTH AND PSYCHIATRIC-DISORDER - A PROSPECTIVE EPIDEMIOLOGIC-STUDY IN YOUNG-ADULTS [J].
BRESLAU, N ;
DAVIS, GC .
JOURNAL OF PSYCHIATRIC RESEARCH, 1993, 27 (02) :211-221
[4]   MEDICATION USE AND DISABILITY AMONG MIGRAINEURS - A NATIONAL PROBABILITY SAMPLE SURVEY [J].
CELENTANO, DD ;
STEWART, WF ;
LIPTON, RB ;
REED, ML .
HEADACHE, 1992, 32 (05) :223-228
[5]   HEALTH-CARE RESOURCE USE AND COSTS ASSOCIATED WITH MIGRAINE IN A MANAGED HEALTH-CARE SETTING [J].
CLOUSE, JC ;
OSTERHAUS, JT .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (05) :659-664
[6]  
DELISSOVOY G, 1994, NEUROLOGY, V44, P56
[7]   IMPACT OF MIGRAINE AND TENSION-TYPE HEADACHE ON LIFE-STYLE, CONSULTING BEHAVIOR, AND MEDICATION USE - A CANADIAN POPULATION SURVEY [J].
EDMEADS, J ;
FINDLAY, H ;
TUGWELL, P ;
PRYSEPHILLIPS, W ;
NELSON, RF ;
MURRAY, TJ .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 20 (02) :131-137
[8]   5-HT1 RECEPTORS IN MIGRAINE PATHOPHYSIOLOGY AND TREATMENT [J].
FERRARI, MD ;
SAXENA, PR .
EUROPEAN JOURNAL OF NEUROLOGY, 1995, 2 (01) :5-21
[9]   A NATIONWIDE SURVEY OF MIGRAINE IN FRANCE - PREVALENCE AND CLINICAL-FEATURES IN ADULTS [J].
HENRY, P ;
MICHEL, P ;
BROCHET, B ;
DARTIGUES, JF ;
TISON, S ;
SALAMON, R .
CEPHALALGIA, 1992, 12 (04) :229-237
[10]   AN UPDATE ON THE EPIDEMIOLOGY OF MIGRAINE [J].
LIPTON, RB ;
SILBERSTEIN, SD ;
STEWART, WF .
HEADACHE, 1994, 34 (06) :319-328